Protocol Summary
Protocol No.
159332 (JAB-2485-1001)
Principal Investigator
Florou, Vaia
Phase
I/II
Age Group
ClinicalTrials.Gov
NCT05490472 (Click to jump to clinicaltrials.gov)
Title
A Phase I/IIa, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-2485 in Adult Patients with Advanced Solid Tumors
Objective
Applicable Disease Sites
Biliary Tract/Gallbladder; Bladder; Brain; Breast; Cervical; Colon/Rectal; Esophageal/Stomach (Gastric); Experimental Therapeutics; Gastrointestinal; Genitourinary; Gynecology; Head/Neck; Kidney (Renal); Leukemia; Liver; Lung; Melanoma; Neuroendocrine; Ovarian/Fallopian Tube; Pancreatic; Prostate; Sarcoma; Uterine/Endometrial
Participating Institutions
Huntsman Cancer Institute
Status
Open
Clinical trials search powered by Forte Research Systems
